Home > About Us
70 %
Proportion of R&D personnel
100 +
Patents and software
10 +
Scene application
4 series
Meet the requirements of process automation in medical institution scenarios
2021

Business opportunity discovery

2022

The stem cell breeding workstation was delivered successfully in January.

In April, the company was established and the client's angel round investment was completed.

The International Joint Stem Cell Research and Development Center was inaugurated in August.

2023

In January, modular standard products of generic key technology R&D were implemented;

In March, Guangzhou Bioisland Laboratory equipment was delivered;

2023-2025 future biomedical scene leading technology enterprise.

2021
2022
2023